Drug Shortage Report for UCERIS
| Report ID | 254642 |
| Drug Identification Number | 02498057 |
| Brand name | UCERIS |
| Common or Proper name | UCERIS |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 2MG |
| Dosage form(s) | FOAM |
| Route of administration | RECTAL |
| Packaging size | 2 foam cans |
| ATC code | A07EA |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-05-15 |
| Actual start date | 2025-05-20 |
| Estimated end date | 2025-08-15 |
| Actual end date | 2025-08-05 |
| Shortage status | Resolved |
| Updated date | 2025-08-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2025-08-06 | French | Compare |
| v10 | 2025-08-06 | English | Compare |
| v9 | 2025-07-16 | French | Compare |
| v8 | 2025-07-16 | English | Compare |
| v7 | 2025-05-29 | French | Compare |
| v6 | 2025-05-29 | English | Compare |
| v5 | 2025-05-21 | French | Compare |
| v4 | 2025-05-21 | English | Compare |
| v3 | 2025-05-16 | English | Compare |
| v2 | 2025-04-09 | French | Compare |
| v1 | 2025-04-09 | English | Compare |
Showing 1 to 11 of 11